196 related articles for article (PubMed ID: 9923515)
1. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.
Grif K; Dierich MP; Karch H; Allerberger F
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):761-6. PubMed ID: 9923515
[TBL] [Abstract][Full Text] [Related]
2. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.
Ochoa TJ; Chen J; Walker CM; Gonzales E; Cleary TG
Antimicrob Agents Chemother; 2007 Aug; 51(8):2837-41. PubMed ID: 17526759
[TBL] [Abstract][Full Text] [Related]
3. Colistin inhibits E. coli O157:H7 Shiga-like toxin release, binds endotoxins and protects Vero cells.
Percivalle E; Monzillo V; Pauletto A; Marone P; Imberti R
New Microbiol; 2016 Apr; 39(2):119-23. PubMed ID: 27196550
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Kurioka T; Yunou Y; Harada H; Kita E
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):561-71. PubMed ID: 10517193
[TBL] [Abstract][Full Text] [Related]
5. Effects of ampicillin, gentamicin, and cefotaxime on the release of Shiga toxins from Shiga toxin-producing Escherichia coli isolated during a diarrhea episode in Faisalabad, Pakistan.
Mohsin M; Haque A; Ali A; Sarwar Y; Bashir S; Tariq A; Afzal A; Iftikhar T; Saeed MA
Foodborne Pathog Dis; 2010 Jan; 7(1):85-90. PubMed ID: 19785532
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
[TBL] [Abstract][Full Text] [Related]
7. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I.
Walterspiel JN; Ashkenazi S; Morrow AL; Cleary TG
Infection; 1992; 20(1):25-9. PubMed ID: 1563808
[TBL] [Abstract][Full Text] [Related]
8. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
[TBL] [Abstract][Full Text] [Related]
9. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.
Zhang X; McDaniel AD; Wolf LE; Keusch GT; Waldor MK; Acheson DW
J Infect Dis; 2000 Feb; 181(2):664-70. PubMed ID: 10669353
[TBL] [Abstract][Full Text] [Related]
10. Effects of antimicrobials on Shiga toxin production in high-virulent Shiga toxin-producing Escherichia coli.
Ramstad SN; Taxt AM; Naseer U; Wasteson Y; Bjørnholt JV; Brandal LT
Microb Pathog; 2021 Mar; 152():104636. PubMed ID: 33242644
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
[TBL] [Abstract][Full Text] [Related]
12. Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response.
Nassar FJ; Rahal EA; Sabra A; Matar GM
Foodborne Pathog Dis; 2013 Sep; 10(9):805-12. PubMed ID: 23808851
[TBL] [Abstract][Full Text] [Related]
13. Cinnamon Oil Inhibits Shiga Toxin Type 2 Phage Induction and Shiga Toxin Type 2 Production in Escherichia coli O157:H7.
Sheng L; Rasco B; Zhu MJ
Appl Environ Microbiol; 2016 Nov; 82(22):6531-6540. PubMed ID: 27590808
[TBL] [Abstract][Full Text] [Related]
14. Different classes of antibiotics differentially influence shiga toxin production.
McGannon CM; Fuller CA; Weiss AA
Antimicrob Agents Chemother; 2010 Sep; 54(9):3790-8. PubMed ID: 20585113
[TBL] [Abstract][Full Text] [Related]
15. Antibacterials that are used as growth promoters in animal husbandry can affect the release of Shiga-toxin-2-converting bacteriophages and Shiga toxin 2 from Escherichia coli strains.
Köhler B; Karch H; Schmidt H
Microbiology (Reading); 2000 May; 146 ( Pt 5)():1085-1090. PubMed ID: 10832635
[TBL] [Abstract][Full Text] [Related]
16. Phylogenetic analysis and Shiga toxin production profiling of Shiga toxin-producing/enterohemorrhagic Escherichia coli clinical isolates.
Li R; Harada T; Honjoh K; Miyamoto T
Microb Pathog; 2010 Nov; 49(5):246-51. PubMed ID: 20558273
[TBL] [Abstract][Full Text] [Related]
17. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
18. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
[TBL] [Abstract][Full Text] [Related]
19. Lactate dehydrogenase release assay from Vero cells to distinguish verotoxin producing Escherichia coli from non-verotoxin producing strains.
Roberts PH; Davis KC; Garstka WR; Bhunia AK
J Microbiol Methods; 2001 Jan; 43(3):171-81. PubMed ID: 11118652
[TBL] [Abstract][Full Text] [Related]
20. Regulatory elements of stx2 gene and the expression level of Shiga-like toxin 2 in Escherichia coli O157:H7.
Suardana IW; Pinatih KJP; Widiasih DA; Artama WT; Asmara W; Daryono BS
J Microbiol Immunol Infect; 2018 Feb; 51(1):132-140. PubMed ID: 27317410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
